Creo Medical Group PLC Share Price
Equities
CREO
GB00BZ1BLL44
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
36.5 GBX | +3.55% | +3.55% | -20.65% |
15/05 | Creo Medical on track to break even next year on strong 2023 results | AN |
15/05 | Creo Medical Group PLC Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2023 | 30.8M 39.22M 3.27B | Sales 2024 * | 40.37M 51.41M 4.29B | Capitalization | 127M 162M 13.52B |
---|---|---|---|---|---|
Net income 2023 | -21M -26.74M -2.23B | Net income 2024 * | -14M -17.83M -1.49B | EV / Sales 2023 | 5.2 x |
Net cash position 2023 * | 22.03M 28.05M 2.34B | Net cash position 2024 * | 132K 168K 14.03M | EV / Sales 2024 * | 3.15 x |
P/E ratio 2023 |
-6.57
x | P/E ratio 2024 * |
-9.36
x | Employees | 279 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 79.14% |
1 day | +3.55% | ||
1 week | +3.55% | ||
1 month | +2.10% | ||
3 months | +17.74% | ||
6 months | +12.31% | ||
Current year | -20.65% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | - | - | |
Craig Gulliford
CEO | Chief Executive Officer | - | 01/12/01 |
President | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Charles Spicer
CHM | Chairman | 59 | 01/16/01 |
John Bradshaw
BRD | Director/Board Member | 60 | - |
Craig Gulliford
CEO | Chief Executive Officer | - | 01/12/01 |
Date | Price | Change | Volume |
---|---|---|---|
31/24/31 | 36.5 | +3.55% | 1,296,494 |
30/24/30 | 35.25 | -.--% | 229,773 |
29/24/29 | 35.25 | -.--% | 220,118 |
28/24/28 | 35.25 | -.--% | 741,956 |
24/24/24 | 35.25 | -.--% | 284,428 |
Delayed Quote London S.E., May 31, 2024 at 09:05 pm IST
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-20.65% | 162M | |
+75.69% | 12.57B | |
-24.68% | 7.34B | |
+12.58% | 5.39B | |
-16.63% | 4.84B | |
+26.90% | 4.53B | |
-21.14% | 3.91B | |
-22.99% | 2.91B | |
+47.42% | 2.37B | |
-0.37% | 2B |
- Stock Market
- Equities
- CREO Stock